companydata.dkcompanydata.dk

BACH BOLIGCENTER ApS: Financial statements 2024

CVR: 12024584

Source: annual report 2024, Danish Business Authority

01/05/2023 – 31/03/2024

BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -19,656 and a net result of DKK 38,084 compared with DKK -200,720 the year before. Equity in the 2024 report amounted to DKK 403,549. The solvency ratio was 95.8%. The company had 1 employee in the financial year.

Gross Profit
DKK -19,656
Profit/Loss
DKK 38,084
Equity
DKK 403,549
Total Assets
DKK 421,377
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--20K38K404K1
2023--15K-201K424K1
2022--14K-153K682K1
2021--13K-9K892K1
2020--14K-166K956K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

About BACH BOLIGCENTER ApS

BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.

Source: annual report 2026, Danish Business Authority